MedTrace Logo

Safety Study of the VEGA UV-A System to Treat Keratoconus

NCT01190306 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 127

Last updated 2022-07-12

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL), when used to treat keratoconus.

Conditions

  • Keratoconus

Interventions

DEVICE

The VEGA UV-A Illumination System

This is a portable electronic device designed to deliver a dose of UV-A light to the treatment area

DRUG

Riboflavin

Riboflavin is a solution that will be delivered to the treatment area

Sponsors & Collaborators

  • Topcon Medical Systems, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01190306 on ClinicalTrials.gov